0001127602-12-008916.txt : 20120301
0001127602-12-008916.hdr.sgml : 20120301
20120301162836
ACCESSION NUMBER: 0001127602-12-008916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120228
FILED AS OF DATE: 20120301
DATE AS OF CHANGE: 20120301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERSTEIN DAVID L
CENTRAL INDEX KEY: 0001242986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 12658138
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0304
4
2012-02-28
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001242986
BERSTEIN DAVID L
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
Senior VP, Chief IP Officer
Common Stock
2012-02-28
4
M
0
10200
3.90
A
208456
D
Common Stock
2012-02-28
4
M
0
1175
4.19
A
209631
D
Common Stock
2012-02-28
4
S
0
11375
15.50
D
198256
D
Employee Stock Option (Right to Buy)
3.90
2012-02-28
4
M
0
10200
0
D
2003-08-15
2013-08-15
Common Stock
10200
0
D
Employee Stock Option (Right to Buy)
4.19
2012-02-28
4
M
0
1175
0
D
2003-06-18
2012-06-18
Common Stock
1175
0
D
Shares were acquired upon the exercise of outstanding stock options at $3.90 per share.
Shares were acquired upon the exercise of outstanding stock option at $4.19 per share.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2012-02-29